13D/13G Filings - Y-mAbs Therapeutics Inc. (YMAB)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
4:00 pm
Sale
2020-12-31 13G Y-mAbs Therapeutics, Inc.
YMAB
HBM BIOVENTURES CAYMAN LTD 2,130,373
5.300%
-657,452decrease
(-23.58%)
Filing
History
2021-02-04
11:48 am
Sale
2020-12-31 13G Y-mAbs Therapeutics, Inc.
YMAB
WELLINGTON MANAGEMENT CO LLP 2,439,809
6.020%
-16,817decrease
(-0.68%)
Filing
History
2021-02-02
3:13 pm
Purchase
2020-12-31 13G Y-mAbs Therapeutics, Inc.
YMAB
BLACKROCK INC
BLK
2,418,580
6.000%
452,462increase
(+23.01%)
Filing
History
2020-08-27
4:54 pm
Sale
2019-09-10 13G Y-mAbs Therapeutics, Inc.
YMAB
Cheung Nai-Kong V 1,897,132
4.740%
-529,268decrease
(-21.81%)
Filing
History
2020-08-25
6:22 pm
Purchase
2018-08-24 13G Y-mAbs Therapeutics, Inc.
YMAB
Cheung Nai-Kong V 2,426,400
8.640%
2,426,400increase
(New Position)
Filing
History
Goto Prev, 0, 1